|
|
|
|
|
|
Companies > Preclinical
|
|
|
Cleveland Heart is a partnership between the Cleveland Clinic and TransWorld Medical Devices. The company is developing the SMARTHEART™ VAD, which is the only continuous flow VAD that automatically adjusts pumping flow for the patient based on activity levels and physical requirements. The design incorporates a completely suspended rotating element for limitless mechanical lifespan, and also allows for remote monitoring capability.
Funders:
Second Generation Fund
|
|
|
|
|